0

Rockefeller University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 17-May-2017
No. of pages: 42

Summary

Rockefeller University (Rockefeller) is an educational and research university that offers various educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics. The university conducts clinical and basic research and also studies a range of range of biological and biomedical problems. It offers research services in various areas such as chemical and structural biology, genetics and genomics, molecular and cell biology, neurosciences and behavior, immunology, virology and microbiology, medical sciences, systems physiology and human genetics, organismal biology, evolution, ethology and ecology, physical, mathematical and computational biology and stem cells, development, regeneration and aging. The university operates through its various laboratories working in a wide range of fields. Rockefeller is headquartered in New York, the US.

Rockefeller University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rockefeller University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Rockefeller University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rockefeller University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ContraFect Enters into Research Agreement with Rockefeller University 11
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 11
QR Pharma Enters into Research Agreement with Rockefeller University 12
Licensing Agreements 13
Cerevance Enters into Licensing Agreement with Rockefeller University 13
Lodo Therapeutics Enters into Licensing Agreement with Rockefeller University 14
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 14
NeoStem Enters into Licensing Agreement with Rockefeller University for Patented Technologies 15
ContraFect Enters Into Licensing Agreement With Rockefeller University 16
Rockefeller University - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Strategy And Business Planning 21
Oct 31, 2016: Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept 21
Government and Public Interest 23
Mar 06, 2017: A new way to reset gene expression in cancer cells shows promise for leukemia treatment 23
Feb 24, 2017: New structural studies reveal workings of a molecular pump that ejects cancer drugs 25
Feb 03, 2017: Atomic-scale view of bacterial proteins offers path to new tuberculosis drugs 26
Dec 06, 2016: Researchers discover a new gatekeeper controlling T cell release into the bloodstream 27
Nov 23, 2016: Study shows low-dose chemotherapy regimens could prevent tumor recurrence in some cancers 28
Sep 29, 2016: Rockefeller University awarded $27 million NIH grant to fund clinical and translational science in Hospital 29
Sep 22, 2016: A compound that stops cells from making protein factories could lead to new antifungal drugs 30
Jul 13, 2016: The Wistar Institute and Partners Receive Nearly $23 Million from NIH to Advance HIV Cure Research 31
May 30, 2016: A combined approach to treating metastatic melanoma 32
Apr 25, 2016: Fisher Center Scientists Discover Pathway That may Lead to Alzheimer's Disease 33
Mar 01, 2016: New research clarifies how stem cells get activated to produce new hair—and what happens when their regenerative powers wear out 34
Feb 03, 2016: Study reveals how herpes virus tricks the immune system 35
Jan 14, 2016: Signals that make early stem cells identified 36
Product News 37
05/05/2016: Broadly neutralizing antibodies improve immune response; clear HIV reservoirs 37
02/06/2017: Encouraging clinical results for an antibody drug to prevent or treat HIV 38
01/17/2017: Successful antibody trial in HIV-infected individuals 39
Clinical Trials 40
May 06, 2016: Antibody therapy opens door to potential new treatment for HIV 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Rockefeller University, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rockefeller University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rockefeller University, Deals By Therapy Area, 2011 to YTD 2017 9
Rockefeller University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
ContraFect Enters into Research Agreement with Rockefeller University 11
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 11
QR Pharma Enters into Research Agreement with Rockefeller University 12
Cerevance Enters into Licensing Agreement with Rockefeller University 13
Lodo Therapeutics Enters into Licensing Agreement with Rockefeller University 14
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 14
NeoStem Enters into Licensing Agreement with Rockefeller University for Patented Technologies 15
ContraFect Enters Into Licensing Agreement With Rockefeller University 16
Rockefeller University, Key Competitors 18
Rockefeller University, Key Employees 19

List of Figures
Rockefeller University, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Rockefeller University, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2021 RnR Company Profiles. All rights reserved.